Read + Share
Amedeo Smart
Independent Medical Education
Mruwat N, Givon-Lavi N, Ludwig RJ, Kridin K, et al. The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study. Int J Dermatol 2025 Jul 7. doi: 10.1111/ijd.17923.PMID: 40928112
Email
LinkedIn
Privacy Policy